Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Edwards Lifesciences (EW) Acquisitions (2016 - 2019)

Edwards Lifesciences has reported Acquisitions over the past 6 years, most recently at $65.2 million for Q2 2019.

For Q2 2019, Acquisitions changed N/A year-over-year to $65.2 million; the TTM value through Sep 2020 reached $65.2 million, down 34.93%, while the annual FY2019 figure was $100.2 million, N/A changed from the prior year.
Acquisitions for Q2 2019 was $65.2 million at Edwards Lifesciences, up from $35.0 million in the prior quarter.
Over five years, Acquisitions peaked at $320.8 million in Q3 2015 and troughed at -$200000.0 in Q1 2017.
A 4-year average of $57.5 million and a median of $11.5 million in 2015 define the central range for Acquisitions.
On a YoY basis, Acquisitions climbed as much as 4220.0% in 2017 and fell as far as 110.0% in 2017.
Year by year, Acquisitions stood at $11.5 million in 2015, then tumbled by 78.26% to $2.5 million in 2016, then surged by 4220.0% to $108.0 million in 2017, then plummeted by 39.63% to $65.2 million in 2019.
Business Quant data shows Acquisitions for EW at $65.2 million in Q2 2019, $35.0 million in Q1 2019, and $108.0 million in Q4 2017.